Search

Author/Creator Hodson, A.

2. Advanced Hodgkin lymphoma in the east of England cancer network: A 10‐year comparative analysis of outcomes for ABVD and escalated‐BEACOPP treated patients aged 16 to 59. (June 2017)

Authors:
Russell, J.; Collins, A.; Fowler, A.; Karanth, M.; Saha, C.; Shyamsundar, V.; Docherty, S.; Kirkwood, A.; Maw, K.; Cooke, L.; Hodson, A.; Shah, N.; Sadullah, S.; Grigoropoulos, N.; Uttenthal, B.; Follows, G.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
318
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P1141: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: A MULTICENTRE, REAL-WORLD UK STUDY. (23rd June 2022)

Authors:
Tivey, A.; Shotton, R.; Eyre, T. A.; Lewis, D.; Crosbie, N.; Nga, E.; Guerrero Camacho, R.; Swe, W.; Marr, H.; Rees, C.; Moule, S.; Sutton, T.; Wrench, D.; Thomas, N.; Wilson, M.; Bailey, J.; Prahladan, M.; Hodson, A.; Koppana, M.; Smith, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1031
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗